U-Chart Analysis:KYORIN Pharmaceutical Co., Ltd.:4569

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KYORIN Pharmaceutical Co., Ltd. Go to web site 4569 Medicals 東証プライム March 1, 2000 2006.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KYORIN Pharmaceutical Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2024年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 13,886 19,394 26,994 27,445 31,925
Other Current AssetsHelp 105,354 99,636 89,382 86,582 85,133
Tangible Fixed AssetsHelp 28,950 25,834 24,334 23,896 22,721
Intangible Fixed AssetHelp 5,088 5,393 3,289 3,785 3,332
Investments and OthersHelp 24,349 25,788 27,925 25,418 28,049
Total AssetsHelp 177,627 176,045 171,924 167,126 171,160
Total Current LiabilitiesHelp 46,333 39,741 36,240 31,020 47,912
Total Long-term LiabilitiesHelp 559 10,843 11,177 11,445 538
Shareholder's EquityHelp 130,735 125,461 124,507 124,661 122,710
Total LiabilitiesHelp 177,627 176,045 171,924 167,126 171,160

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2024年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 119,532 113,270 105,534 102,904 109,983
Total Sales 119,532 113,270 105,534 102,904 109,983
Cost of SalesHelp 68,124 63,102 56,093 51,276 52,950
Other Costs and RevenueHelp 46,085 45,444 45,509 45,498 50,884
Total CostsHelp 114,209 108,546 101,602 96,774 103,834
Net RevenueHelp 51,408 50,168 49,441 51,628 57,033
Earnings Before TaxHelp 7,019 6,906 5,216 8,352 8,255
Net IncomeHelp 5,323 4,724 3,932 6,130 6,149
Net Income 5,323 4,724 3,932 6,130 6,149

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2024年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 1,517 1,924 6,347 5,187 7,678
Investing Cash Flow(ICF)Help -3,187 -6,275 -2,560 -4,259 -2,943
Financing Cash FlowHelp -3,347 -3,363 -4,112 -4,918 -5,117
Exchange Difference of Cash and Cash EquivalentsHelp 87 241 139 -43 -22
Net Increase and Decrease in Cash and Cash Equivalentsn -4,930 -7,473 -186 -4,033 -404

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KYORIN Pharmaceutical Co., Ltd.

Company where related level is highHelp

CanBas Co.,Ltd.
STELLA PHARMA CORPORATION
GNI Group Ltd.
RIBOMIC Inc.
EIKEN CHEMICAL CO.,LTD.
DENKA SEIKEN Co.,Ltd.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
Nxera Pharma Co., Ltd.
CellSource Co., Ltd.
Nichi-Iko Pharmaceutical Co.,Ltd.